Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/jRCT1030230122
jRCT1030230122RecruitingNot Applicable

A Study on Optimizing Setup Margins in Carbon Ion Radiotherapy

National Institutes for Quantum Science and Technology0 sites750 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
750
Primary Endpoint
Systematic organization of deviations and trends in marker positions
Study OverviewEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
No limit to No limit (—)

Inclusion Criteria

  • •Patients treated with Carbon-ion radiotherapy for lung, prostate, liver, breast, and kidney at QST Hospital between March 2020 and February 2023 after gold marker insertion are eligible.

Exclusion Criteria

  • •Patients whose gold marker location information is not stored.
  • •Patients who have requested to refuse the use of their information for this study.

Outcomes

Primary Outcomes

Systematic organization of deviations and trends in marker positions

Systematically organize the deviations and trends in marker positions for each treated organ, pre-treatment, and irradiated body position

Determination of setup margin

Determine the setup margin for each condition

Secondary Outcomes

No secondary outcomes reported

Investigators

Similar Trials

Recruiting
Unknown
A Study on Optimizing Setup Margins in Carbon Ion Radiotherapyung cancer, prostate cancer, liver cancer, breast cancer, kidney cancerD008175, D011471, D008113, D001943, D007680
JPRN-jRCT1030230122Okonogi Noriyuki750
Completed
Not Applicable
Carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trialRecurrent gliomaMalignant neoplasm of brainCancer
ISRCTN01460925niversity Hospital of Heidelberg (Germany)436
Recruiting
Not Applicable
Prospective observational study of Carbon ion radiotherapy for solitary fibrous tumorsolitary fibrous tumor
JPRN-UMIN000048444ational Institutes for Quantum Science and Technology15
Recruiting
Not Applicable
A prospective observation study of carbon-ion radiotherapy and concurrent S-1 chemotherapy for locally advanced pancreatic cancer (GUNMA1501)ocally advanced pancreatic cancer
JPRN-UMIN000023602Gunma University Heavy Ion Medical Center20
Not yet recruiting
Unknown
Improving the accuracy of carbon-ion beam dose calculations using Dual Energy CTHead and neck cancer
JPRN-UMIN000052288ational Institutes for Quantum Science and Technology10